Cargando…
A 12-week prospective randomized controlled comparative trial of vilazodone and sertraline in Indian patients with depression
BACKGROUND: Depressive disorders are considered to be one of the leading causes of morbidity and mortality accounting for 4.3% of total disability-adjusted life years. Selective serotonin reuptake inhibitors and serotonin–norepinephrine reuptake inhibitors have greater efficacy and lesser side effec...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074431/ https://www.ncbi.nlm.nih.gov/pubmed/32201441 http://dx.doi.org/10.4103/ijp.IJP_618_18 |